Recent News
Press Releases
28-04-2021 09:26
Reference to the Informal 5+1 Meeting on Cyprus during the UN press briefing
During yesterday’s (27.04.21) international press briefing at UN Headquarters, the Deputy Spokesperson for the Secretary‑General, Mr Farhan Haq, read out the following statement:"The informal meeting of the 5+1 on the Cyprus issue got underway in Geneva a few hours ago. As you know, the Secretary-General decided to organize this meeting following the consultations conducted over the past several months on his behalf by Under-Secretary-General Jane Holl Lute. Not long ago, the Secretary-Gen...
27-04-2021 23:35
Photo Album - President of the Republic – National Council meeting
The President of the Republic, Mr Nicos Anastasiades, presides over a meeting of the National Council at Geneva.
27-04-2021 22:39
Photo Album - Informal five-party Summit – Reception
The UN Secretary General, Mr António Guterres, hosts a reception for the participants of the Informal five-party Summit on the Cyprus issue, in Palais des Nations, in Geneva.
27-04-2021 21:28
Photo Album - PoR – Minister of Foreign Affairs of the Hellenic Republic
The President of the Republic, Mr Nicos Anastasiades, at a meeting with the Minister of Foreign Affairs of the Hellenic Republic, Mr Nikos Dendias, in Geneva.
27-04-2021 19:48
Photo Album - PoR – UN Secretary General – Informal five-party Summit
Bilateral meeting between the President of the Republic, Mr Nicos Anastasiades, and the United Nations Secretary General, Mr António Guterres, in Palais des Nations, in Geneva.
27-04-2021 15:15
Rapid antigen testing for employees and the general population – Testing units 28 April 2021
Aiming at the continuous surveillance of the community and the workplaces, the free programmes of rapid antigen testing of the general population and employees are in progress.For the smooth and safe operation of businesses that have been activated according to the Decrees, employers in businesses, as well as the Heads of Departments/Services in the public and wider public sector, are obliged to coordinate the rapid testing of the employees, so that the mandatory weekly testing of the person...
27-04-2021 14:30
Vaccination against COVID-19 – Answers to frequently asked questions
1. Which vaccines are licensed and available for vaccination? The vaccines against COVID-19 that have been licensed by the European Medicines Agency (EMA) are: Pfizer/BioNTech, AstraZeneca, Moderna and Johnson&Johnson.2. What is the interval period between the 1st and 2nd dose of each vaccine?Pfizer/BioNTech: The Pfizer/BioNTech vaccine is administered in two doses, with an interval period of 3 weeks between the two doses.AstraZeneca: The AstraZeneca vaccine is administered in t...
27-04-2021 14:22
Imports, sales and stocks of petroleum products: March 2021 Annual change in sales +2,5%
In March 2021, the total sales of petroleum products amounted to 108.447 tonnes, recording an increase of 2,5% compared to March 2020. A fall was observed in the provisions of aviation kerosene by 64,9%. On the contrary, an increase was recorded in the sales of motor gasoline by 28,8% and road diesel by 30,4%. As far as the sales from filling stations are specifically concerned, these have registered a rise of 28,8% to 55.565 tonnes.The total sales of petroleum products in March 2021 compare...
27-04-2021 12:25
Revised list of clinical laboratories conducting rapid antigen tests
The Ministry of Health, taking into account the recommendations of the European Commission and the European Centre for Disease Prevention and Control (ECDC), for the minimum standards that the SARS-CoV-2 rapid antigen tests must meet, has compiled a list of laboratories that carry out tests with these specifications.In addition, the Ministry of Health informs citizens that rapid antigen tests using saliva are currently being evaluated at an EU level by the member states, as there are still i...
27-04-2021 10:36
The period of administration of the 2nd dose of the AstraZeneca vaccine is reduced to eight weeks
After reviewing and evaluating the data arising from international studies on real vaccinations, as well as the recommendation in the Instructions for Use Leaflet of the AstraZeneca Vaccine, it was decided to reduce the period between the 1st and the 2nd dose of this vaccine from 12 to eight (8) weeks.The decision is implemented as of today, and arrangements have already been made at the Vaccination Centres, so that the appointments for the 2nd dose of the vaccine for those who will be vacci...
PRESS AND INFORMATION OFFICE
